SG11201907441WA - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
SG11201907441WA
SG11201907441WA SG11201907441WA SG11201907441WA SG11201907441WA SG 11201907441W A SG11201907441W A SG 11201907441WA SG 11201907441W A SG11201907441W A SG 11201907441WA SG 11201907441W A SG11201907441W A SG 11201907441WA SG 11201907441W A SG11201907441W A SG 11201907441WA
Authority
SG
Singapore
Prior art keywords
international
pct
reims
givaudan
hyaluronate
Prior art date
Application number
SG11201907441WA
Other languages
English (en)
Inventor
Martin Lovchik
Gerhard Brunner
Romain Reynaud
Amandine Scandolera
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of SG11201907441WA publication Critical patent/SG11201907441WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11201907441WA 2017-03-10 2018-03-08 Improvements in or relating to organic compounds SG11201907441WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1703850.6A GB201703850D0 (en) 2017-03-10 2017-03-10 Improvements in or relating to organic compounds
PCT/EP2018/055823 WO2018162672A1 (en) 2017-03-10 2018-03-08 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
SG11201907441WA true SG11201907441WA (en) 2019-09-27

Family

ID=58605525

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907441WA SG11201907441WA (en) 2017-03-10 2018-03-08 Improvements in or relating to organic compounds

Country Status (12)

Country Link
US (2) US20210128442A1 (ja)
EP (1) EP3592330A1 (ja)
JP (2) JP7295802B2 (ja)
KR (2) KR20190122784A (ja)
CN (1) CN110392565A (ja)
AU (1) AU2018232835B2 (ja)
CO (1) CO2019008987A2 (ja)
GB (1) GB201703850D0 (ja)
IL (1) IL268682B (ja)
MX (1) MX2019009711A (ja)
SG (1) SG11201907441WA (ja)
WO (1) WO2018162672A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3104987B1 (fr) 2019-12-18 2023-06-30 Lvmh Rech Composition cosmétique comprenant de l’acide 2-glucoside ascorbique et de l’acide hyaluronique acétylé ou l’un de ses sels
CN111297727A (zh) * 2019-12-25 2020-06-19 华熙生物科技股份有限公司 一种美塑治疗组合物及其应用
WO2021212267A1 (en) * 2020-04-20 2021-10-28 L'oreal Composition for caring for the skin
CN113509442A (zh) * 2021-06-21 2021-10-19 浙江宜格企业管理集团有限公司 一种含补骨脂酚的脂质体及其制备方法
CN114191331B (zh) * 2021-12-10 2023-07-07 华熙生物科技股份有限公司 抗皮肤衰老组合物及其用途和抗皮肤衰老产品
FR3130138A1 (fr) 2021-12-10 2023-06-16 L V M H Recherche Composition de lissage de la peau et/ou des lèvres

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3142415B2 (ja) * 1992-04-21 2001-03-07 株式会社資生堂 高アセチル化率ヒアルロン酸及びその製造方法
JP3556975B2 (ja) * 1994-08-11 2004-08-25 株式会社資生堂 アセチル化ヒアルロン酸の製造方法及び精製方法
US5679657A (en) * 1994-08-11 1997-10-21 Shiseido Co., Ltd. Low molecular weight acetylhyaluronate, skin-softening composition, method of manufacturing the same, and method of purifying the same
JP3557044B2 (ja) * 1995-06-29 2004-08-25 株式会社資生堂 皮膚柔軟化剤
JPH10265332A (ja) * 1997-03-26 1998-10-06 Shiseido Co Ltd 水中油型乳化組成物
JP3634113B2 (ja) * 1997-03-31 2005-03-30 株式会社資生堂 皮膚外用剤
JP3634112B2 (ja) * 1997-03-31 2005-03-30 株式会社資生堂 皮膚外用剤
JP3667491B2 (ja) * 1997-03-31 2005-07-06 株式会社資生堂 皮膚外用剤
JPH10279418A (ja) * 1997-03-31 1998-10-20 Shiseido Co Ltd 皮膚外用剤
JPH10279426A (ja) * 1997-03-31 1998-10-20 Shiseido Co Ltd 皮膚外用剤
JP3667490B2 (ja) * 1997-03-31 2005-07-06 株式会社資生堂 皮膚外用剤
JPH10279425A (ja) * 1997-03-31 1998-10-20 Shiseido Co Ltd 皮膚外用剤
CH692919A5 (fr) * 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
JP2005068073A (ja) * 2003-08-25 2005-03-17 Takashi Fukazawa 目元用化粧料
JP2006306842A (ja) * 2005-03-30 2006-11-09 Kose Corp 二層型紫外線防御化粧料
WO2008134712A2 (en) * 2007-04-30 2008-11-06 Living Proof, Inc. Use of matrix metalloproteinase inhibitors in skin care
JP2008280430A (ja) * 2007-05-10 2008-11-20 Mitsubishi Rayon Co Ltd ヒアルロン酸の製造方法
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles
JP4781464B2 (ja) * 2009-12-21 2011-09-28 株式会社 資生堂 シート状化粧料
JP6071123B2 (ja) * 2012-02-10 2017-02-01 株式会社 資生堂 水中油型乳化皮膚化粧料
ITMI20121184A1 (it) * 2012-07-05 2014-01-06 Altergon Italia Srl Processo per la produzione industriale di ialuronato di sodio (hana) altamente purificato a peso molecolare controllato
KR20150015209A (ko) * 2013-07-31 2015-02-10 주식회사 피코테라 저분자 아세틸화 히알루론산의 제조방법 및 이의 용도
CN106109296B (zh) * 2016-06-30 2018-02-09 彭燕辉 一种保湿精华水及其制备方法
CN106176286B (zh) * 2016-08-30 2019-05-28 华熙生物科技股份有限公司 透明质酸皮肤护理膜及制备方法和应用

Also Published As

Publication number Publication date
JP7295802B2 (ja) 2023-06-21
JP2020510034A (ja) 2020-04-02
MX2019009711A (es) 2019-10-02
KR20190122784A (ko) 2019-10-30
EP3592330A1 (en) 2020-01-15
JP2023156270A (ja) 2023-10-24
IL268682B (en) 2022-07-01
RU2019128243A (ru) 2021-04-12
BR112019017224A2 (pt) 2020-04-14
WO2018162672A1 (en) 2018-09-13
RU2019128243A3 (ja) 2021-05-11
AU2018232835B2 (en) 2024-01-18
US11766393B2 (en) 2023-09-26
US20210128442A1 (en) 2021-05-06
CN110392565A (zh) 2019-10-29
US20210369592A1 (en) 2021-12-02
GB201703850D0 (en) 2017-04-26
IL268682A (en) 2019-10-31
KR20240064056A (ko) 2024-05-10
AU2018232835A1 (en) 2019-09-05
CO2019008987A2 (es) 2020-01-17

Similar Documents

Publication Publication Date Title
SG11201907441WA (en) Improvements in or relating to organic compounds
SG11201807185UA (en) Modified hyaluronic acid, method for making same and uses thereof
SG11201809912UA (en) Hybrid carriers for nucleic acid cargo
SG11201901390TA (en) Tetracycline compounds and methods of treatment
SG11201408261UA (en) Syringe
SG11201408605UA (en) Methods for biodegradable derivatization of cellulosic surfaces
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201908472VA (en) Compositions and methods for activating nk cells
SG11201808713YA (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
SG11201906041QA (en) Pharmaceutical compositions for combination therapy
SG11201909419XA (en) Hydrogel for cell culture and biomedical applications
SG11201805001UA (en) Method of treating influenza a
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201907421QA (en) Chemical composition
SG11201805149XA (en) Compositions comprising 15-hepe and methods of using the same
SG11201909837YA (en) Methods for treating lung disorders
SG11201903427UA (en) Deodorizing agent comprising zinc neodecanoate
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201901249YA (en) Aza-indazole compounds for use in tendon and/or ligament injuries
SG11201909872WA (en) Stability of short path evaporation treated oils
SG11201900123TA (en) Compositions and methods for treating frontotemporal dementia
SG11201806127XA (en) Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate
SG11201901624RA (en) Lysine specific histone demethylase-1 inhibitors and uses therefor
SG11201910183SA (en) C-terminal cdnf and manf fragments, pharmaceutical compositions comprising same and uses thereof